BIOHK2022 IN ASIA'S NO 1 BIOTECH IPO MARKET BUSINESS DEVELOPMENT & EMERGENT OPPORTUNITIES IN BIOTECH 香港国际生物科技展在亚洲最大生物科技IPO市场中举办 生物科技发展和新兴机会 ROBUST 健全 As the biotech sector continues to grow at an exponential rate, it is important that we continue this momentum and further accelerate Hong Kong’s position as a biotech innovation hub. With the government’s support, Hong Kong is prioritising biotechnology and innovation. 随着生物科技行业继续迅速增长,我们必须保持这一势头,进一步提高香港作为生物科技创新中心的地位。 在政府的支持下,香港正在优先发展生物科技和创新。 IMPORTANT 重要 At BIOHK2022 government officials, industry leaders of the Pharma and Biotech industry and key investors evaluate the opportunities for biotech and innovation in China and Hong Kong, explore policies in cultivating and recruiting talent, highlight the importance of fostering national and international collaboration, focus on how you can grow your business, target specific markets, keeping up to date with trends in the industry and how to manage risks in business. BIOHK2022’s Business Development and Emergent Opportunities in Biotech session is a must attend for those who are looking to expand and take advantage of the opportunities Hong Kong and China have to offer. 在香港国际生物科技展上,政府官员,制药和生物科技行业的行业领导者以及主要投资者评估了中国和香港的生物科技和创新机会,探讨了培养和招募人才的政策,强调了促进国内和国际合作的重要性,着重于如何 您可以发展自己的业务,定位特定的市场,紧跟行业趋势以及如何管理业务风险。香港国际生物科技展的生物科技发展和新兴机会会议对于那些想要扩展并利用香港和中国大陆提供的机遇的人们来说,必须参加。 CALLING FOR NEW CONFERENCE TOPICS AND SPEAKERS 呼吁新学术演讲题目及嘉宾 ! We are always on the lookout for new conference topics and speakers! If there is a topic that you would like us to feature, or someone you know who would make an excellent addition to our event, feel free to let us know. 我们一直寻找新的学术演讲题目及嘉宾!如果您认识某个精彩的题目或您身边认识一位出色的演讲嘉宾,请随时联络我们以作提名。 TOPICS 题目 WHY BIOTECH AND INNOVATION IS A PRIORITY 为什么生物科技和创新是优先事项 01 WHY DOES HONG KONG SEE BIOTECH AND INNOVATION AS A PRIORITY? WHAT IS BEING DONE TO ACCELERATE THE DEVELOPMENT OF THE INDUSTRY? 香港为什么视生物科技和创新为优先? 加快行业发展将做些什么? (schemes, funding, proposals, projects) (方案,资金,提案,项目) 02 IMPLICATIONS OF BIOTECH AND INNOVATION ACROSS ALL INDUSTRIES – HEALTHCARE, AGRICULTURE, ENVIRONMENTAL AND INDUSTRIAL USE 生物科技和创新对所有行业的影响——卫生保健,农业,环境和工业用途 03 HONG KONG AS ASIA’S BIOTECH INNOVATION HUB 香港作为亚洲的生物科技创新中心 04 EMERGENT OPPORTUNITIES IN THE INDUSTRY: MOVING IN THE CORRECT DIRECTION TO BOOST YOUR BUSINESS’ IMAGE 行业中的新兴商机:朝着正确的方向发展,以提升企业形象 05 TAPPING INTO THE VAST MARKET THE GBA HAS TO OFFER: OPPORTUNITIES & CHALLENGES IN GBA 开拓大湾区广阔的市场:大湾区的机遇与挑战 06 BUILDING YOUR BUSINESS: ACCESSING THE CHINA MARKET AND HONG KONG’S ADVANTAGEOUS POSITION 建立您的业务:进入中国市场和香港的有利位置 07 HOW PHARMA BUSINESS MODELS ARE CHANGING? WHAT ARE THE IMPLICATIONS? 制药业务模式如何转变? 这意味着什么? CULTIVATING AND RECRUITING TALENT 培养和招聘人才 01 CULTIVATING & RECRUITING TALENTS BOTH LOCALLY AND INTERNATIONALLY: STRATEGIES AND BENEFITS 培养和招募本地和海外人才:策略和收益 02 RELAXING POLICIES AND REGULATIONS TO ATTRACT YOUNG TALENT 放宽政策和法规以吸引年轻人才 03 EVALUATING POLICIES, REGULATIONS, SCHEMES AND PROPOSALS THAT HAVE WORKED POSITIVELY IN THE PAST AND HOW WE CAN FURTHER IMPROVE AND IMPLEMENT SUCH REGIMES (CASE STUDIES) 评估过去有效的政策,法规,计划和提案,以及我们如何进一步改善和实施此类制度(案例研究) 04 FOCUSING ON HK'S PIVOTAL ROLE IN PROVIDING OPPORTUNITIES IN BIOTECH AND OUR ADVANTAGES 重视香港在提供生物科技机会方面的重要作用和优势 (geographical location, culture, unique status, therefore more attractive to young talent) (地理位置,文化,独特的地位,因此对年轻人才更具吸引力) 05 THE NEED FOR FUNDING PROCESSES NEED TO BE QUICKER 资金筹措过程更快的需要 06 MAINTAINING YOUNG TALENT 保持年轻人才 Including work from HR departments, talent management, development of jobs 包括人力资源部门的工作,人才管理,职位发展 07 PROVIDING YOUNG TALENT DIRECTION, FROM ACADEMIA TO INNOVATION, ACCELERATING HONG KONG’S DEVELOPMENT AS A BIOTECH INNOVATION HUB 提供从学术到创新的年轻人才方向,加速香港作为生物科技创新中心的发展 FOSTERING NATIONAL AND INTERNATIONAL COLLABORATION 促进国家和国际合作 01 PROMOTING A CHANGE IN ATTITUDE TOWARDS COLLABORATION BETWEEN HIGHER EDUCATION INSTITUTES AND PRIVATE SECTOR 促进高等教育机构与私营部门之间的合作态度变化 02 ADVANTAGES AND BENEFITS OF COMMERCIALISATION FOR UNIVERSITIES 大学商品化的优势与好处 03 CREATING A FORUM BETWEEN GOVERNMENT REPRESENTATIVES, SCIENTISTS IN BOTH THE PRIVATE SECTOR AND UNIVERSITIES TO ADDRESS AND DISCUSS CHALLENGES WHEN COLLABORATING BETWEEN THE SECTORS, AND WHAT THE GOVERNMENT NEEDS TO DO TO PROMOTE HONG KONG AS A BIOTECH INNOVATION HUB 为政府代表,私营部门和大学的科学家之间建立论坛,以解决和讨论部门之间合作时遇到的挑战,以及政府为促进香港成为生物科技创新中心需要采取的行动 04 ACCELERATING INTERNATIONAL COLLABORATION BETWEEN SCIENTIFIC COMMUNITIES 促进科学界之间的国际合作 05 EXPLORE HOW THE GBA CAN ACCELERATE DEVELOPMENT AND FOSTER INTERNATIONAL COLLABORATION OF THE GLOBAL BIOTECHNOLOGY INDUSTRY 探索大湾区如何促进全球生物科技产业的发展及促进国际合作 06 WHAT WE NEED FOR SEAMLESS COLLABORATIVE MECHANISMS BETWEEN SCIENTIFIC COMMUNITIES AND RESOURCES OF CITIES IN THE GBA AND WORLDWIDE 我们需要在科学界与大湾区和全球城市资源之间建立无缝协作机制的条件 FOCUSING ON YOUR COMPANY’S APPLICATIONS TO SPECIFIC REGIONS RATHER THAN ACHIEVING GLOBALISATION 关注您的公司在实现全球化之外的特定区域的应用 01 UNDERSTANDING THE MARKET AND UNDERSTANDING THE NEEDS OF VARIOUS REGIONS IN THE GBA, LEVERAGE THE OPPORTUNITIES THE GBA HAS TO OFFER 了解市场及大湾区各个地区的需求,利用大湾区所提供的机会 MANAGING RISKS IN BUSINESS AND REMAINING CURRENT IN THE INDUSTRY 管理业务风险和保持最新 01 PROTECTING YOUR BUSINESS 保护您的业务 i) Data privacy i)数据隐私 02 MAINTAINING THE BALANCE FOR R&D PRODUCTIVITY: BUYING VS BUILDING 保持研发生产力的平衡:购买或研发 03 THE RELEVANCE OF CLOUD COMPUTING IN CREATING VALUE FROM GENERATED DATA FROM YOUR BUSINESS 云计算在企业从产生的数据中创造价值的关联 04 TRANSFORMING YOUR COMPANY TO BECOME A DATA DRIVEN, DIGITAL DRIVEN COMPANY 转变您的公司成为数据驱动的,数字驱动的公司 05 PRIORITISING DIGITALISATION OF THE INDUSTRY: REMAIN COMPETITIVE, DON'T GET LEFT BEHIND, LEARN FROM THE PAST 优先将行业数字化:保持竞争力,不要落伍及从过去的学习 ...... AND MORE ...... 及更多 BIOHK2022 is the first international biotech convention to be held in Hong Kong and one of the first face-to-face meetings after COVID-19 for all to enjoy. BIOHK will present an exceptional international biotech kaleidoscope event to you. 香港国际生物科技展是首个在香港举行的国际生物科技展,也是2019新型冠状病毒病爆发之后第一批线下会议之一。 BIOHK将为您呈现一场国际生物科技万花筒盛会。 Copyright © 2020 Hong Kong Biotechnology Organisation. All rights reserved. Changed your mind? You can unsubscribe at any time.
版权所有 © 2020 香港生物科技协会 不再想要接收这些电子邮件? 按此退订 |